Copyright Reports & Markets. All rights reserved.

Global Oral Probitoics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Oral Probitoics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Oral Probitoics Market Size Growth Rate by Product
      • 1.4.2 Lozenges
      • 1.4.3 Other
    • 1.5 Market by End User
      • 1.5.1 Global Oral Probitoics Market Size Growth Rate by End User
      • 1.5.2 Human Use
      • 1.5.3 Veterinary
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Oral Probitoics Market Size
      • 2.1.1 Global Oral Probitoics Revenue 2014-2025
      • 2.1.2 Global Oral Probitoics Sales 2014-2025
    • 2.2 Oral Probitoics Growth Rate by Regions
      • 2.2.1 Global Oral Probitoics Sales by Regions
      • 2.2.2 Global Oral Probitoics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Oral Probitoics Sales by Manufacturers
      • 3.1.1 Oral Probitoics Sales by Manufacturers
      • 3.1.2 Oral Probitoics Sales Market Share by Manufacturers
      • 3.1.3 Global Oral Probitoics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oral Probitoics Revenue by Manufacturers
      • 3.2.1 Oral Probitoics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Probitoics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Oral Probitoics Price by Manufacturers
    • 3.4 Oral Probitoics Manufacturing Base Distribution, Product Types
      • 3.4.1 Oral Probitoics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Oral Probitoics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Oral Probitoics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Oral Probitoics Sales by Product
    • 4.2 Global Oral Probitoics Revenue by Product
    • 4.3 Oral Probitoics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Oral Probitoics Breakdown Data by End User

    6 North America

    • 6.1 North America Oral Probitoics by Countries
      • 6.1.1 North America Oral Probitoics Sales by Countries
      • 6.1.2 North America Oral Probitoics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Oral Probitoics by Product
    • 6.3 North America Oral Probitoics by End User

    7 Europe

    • 7.1 Europe Oral Probitoics by Countries
      • 7.1.1 Europe Oral Probitoics Sales by Countries
      • 7.1.2 Europe Oral Probitoics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Oral Probitoics by Product
    • 7.3 Europe Oral Probitoics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Oral Probitoics by Countries
      • 8.1.1 Asia Pacific Oral Probitoics Sales by Countries
      • 8.1.2 Asia Pacific Oral Probitoics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Oral Probitoics by Product
    • 8.3 Asia Pacific Oral Probitoics by End User

    9 Central & South America

    • 9.1 Central & South America Oral Probitoics by Countries
      • 9.1.1 Central & South America Oral Probitoics Sales by Countries
      • 9.1.2 Central & South America Oral Probitoics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Oral Probitoics by Product
    • 9.3 Central & South America Oral Probitoics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Oral Probitoics by Countries
      • 10.1.1 Middle East and Africa Oral Probitoics Sales by Countries
      • 10.1.2 Middle East and Africa Oral Probitoics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Oral Probitoics by Product
    • 10.3 Middle East and Africa Oral Probitoics by End User

    11 Company Profiles

    • 11.1 NatureWise
      • 11.1.1 NatureWise Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 NatureWise Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 NatureWise Oral Probitoics Products Offered
      • 11.1.5 NatureWise Recent Development
    • 11.2 Now Foods
      • 11.2.1 Now Foods Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Now Foods Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Now Foods Oral Probitoics Products Offered
      • 11.2.5 Now Foods Recent Development
    • 11.3 DS Healthcare
      • 11.3.1 DS Healthcare Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 DS Healthcare Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 DS Healthcare Oral Probitoics Products Offered
      • 11.3.5 DS Healthcare Recent Development
    • 11.4 Higher Nature
      • 11.4.1 Higher Nature Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Higher Nature Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Higher Nature Oral Probitoics Products Offered
      • 11.4.5 Higher Nature Recent Development
    • 11.5 NutriPreme
      • 11.5.1 NutriPreme Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 NutriPreme Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 NutriPreme Oral Probitoics Products Offered
      • 11.5.5 NutriPreme Recent Development
    • 11.6 Candidabiotix
      • 11.6.1 Candidabiotix Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Candidabiotix Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Candidabiotix Oral Probitoics Products Offered
      • 11.6.5 Candidabiotix Recent Development
    • 11.7 Hyperbiotics
      • 11.7.1 Hyperbiotics Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Hyperbiotics Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Hyperbiotics Oral Probitoics Products Offered
      • 11.7.5 Hyperbiotics Recent Development
    • 11.8 Jarrow Formulas
      • 11.8.1 Jarrow Formulas Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Jarrow Formulas Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Jarrow Formulas Oral Probitoics Products Offered
      • 11.8.5 Jarrow Formulas Recent Development
    • 11.9 Life Extension
      • 11.9.1 Life Extension Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Life Extension Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Life Extension Oral Probitoics Products Offered
      • 11.9.5 Life Extension Recent Development
    • 11.10 Natren
      • 11.10.1 Natren Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Natren Oral Probitoics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Natren Oral Probitoics Products Offered
      • 11.10.5 Natren Recent Development
    • 11.11 UltraCruz
    • 11.12 Aqua Flora

    12 Future Forecast

    • 12.1 Oral Probitoics Market Forecast by Regions
      • 12.1.1 Global Oral Probitoics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Oral Probitoics Revenue Forecast by Regions 2019-2025
    • 12.2 Oral Probitoics Market Forecast by Product
      • 12.2.1 Global Oral Probitoics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Oral Probitoics Revenue Forecast by Product 2019-2025
    • 12.3 Oral Probitoics Market Forecast by End User
    • 12.4 North America Oral Probitoics Forecast
    • 12.5 Europe Oral Probitoics Forecast
    • 12.6 Asia Pacific Oral Probitoics Forecast
    • 12.7 Central & South America Oral Probitoics Forecast
    • 12.8 Middle East and Africa Oral Probitoics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Oral Probitoics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Oral Probitoics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Probitoics market based on company, product type, end user and key regions.

      This report studies the global market size of Oral Probitoics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Probitoics in these regions.
      This research report categorizes the global Oral Probitoics market by top players/brands, region, type and end user. This report also studies the global Oral Probitoics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      NatureWise
      Now Foods
      DS Healthcare
      Higher Nature
      NutriPreme
      Candidabiotix
      Hyperbiotics
      Jarrow Formulas
      Life Extension
      Natren
      UltraCruz
      Aqua Flora

      Market size by Product
      Lozenges
      Other
      Market size by End User
      Human Use
      Veterinary

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Oral Probitoics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Oral Probitoics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Oral Probitoics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Oral Probitoics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Oral Probitoics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Probitoics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now